Invasive pneumococcal disease: Clinical outcomes and patient characteristics 2–6 years after introduction of 7-valent pneumococcal conjugate vaccine compared to the pre-vaccine period, the Netherlands

Vaccine ◽  
2016 ◽  
Vol 34 (8) ◽  
pp. 1077-1085 ◽  
Author(s):  
Gertjan H.J. Wagenvoort ◽  
Elisabeth A.M. Sanders ◽  
Bart J. Vlaminckx ◽  
Karin E. Elberse ◽  
Hester E. de Melker ◽  
...  
2013 ◽  
Vol 142 (9) ◽  
pp. 1996-1999 ◽  
Author(s):  
S. P. VAN MENS ◽  
A. M. M. VAN DEURSEN ◽  
S. C. A. MEIJVIS ◽  
B. J. M. VLAMINCKX ◽  
E. A. M. SANDERS ◽  
...  

SUMMARYAnalysis of the Dutch national invasive pneumococcal disease (IPD) surveillance data by sex reveals an increase in the incidence of serotype-1 disease in young female adults in The Netherlands after the introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in the national immunization schedule. This has led to an overall increase in IPD in women aged 20–45 years, which was not observed in men of the same age. No other differences in serotype shifts possibly induced by the introduction of PCV7 were observed between the sexes in this age group. Serotype 1 is a naturally fluctuating serotype in Europe and it has been associated with disease in young healthy adults before. It remains uncertain whether or not there is an association between the observed increase in serotype-1 disease in young female adults and the implementation of PCV7 in The Netherlands.


2015 ◽  
Vol 21 (11) ◽  
pp. 2040-2044 ◽  
Author(s):  
Mirjam J. Knol ◽  
Gertjan H.J. Wagenvoort ◽  
Elisabeth A.M. Sanders ◽  
Karin Elberse ◽  
Bart J. Vlaminckx ◽  
...  

2012 ◽  
Vol 18 (11) ◽  
pp. 1729-1737 ◽  
Author(s):  
Anna M.M. van Deursen ◽  
Suzan P. van Mens ◽  
Elisabeth A.M. Sanders ◽  
Bart J.M. Vlaminckx ◽  
Hester E. de Melker ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document